Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies
- 1 September 2001
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 3 (3) , 161-167
- https://doi.org/10.1034/j.1399-3062.2001.003003161.x
Abstract
Invasive aspergillosis remains a significant cause of morbidity and mortality in transplantation, especially lung and allogeneic bone marrow transplant recipients. The epidemiology, classic and newly recognized risk factors, and incidence of aspergillosis are reviewed. Risk factors include environmental exposures, airway colonization, profound immunosuppression, neutropenia, prior cytomegalovirus infection, and renal dysfunction. Clinical and radiographic presentations of invasive aspergillosis are discussed, including some unusual manifestations in lung transplant recipients. Early and accurate diagnosis of aspergillosis remains a challenge, and diagnostic strategies are reviewed, with an emphasis on the chest computerized tomography scan and on transbronchial or open lung biopsy. Recent advances include prophylactic and pre‐emptive antifungal strategies, newer therapeutic agents, and improved risk stratification.Keywords
This publication has 75 references indexed in Scilit:
- Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipientsClinical Transplantation, 2001
- Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosisBone Marrow Transplantation, 1999
- Pre-emptive therapy with azoles in lung transplant patientsEuropean Respiratory Journal, 1999
- Clinical presentation of invasive aspergillosisMycoses, 1997
- Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosisInfection, 1996
- Aspergillus INFECTION IN SINGLE AND DOUBLE LUNG TRANSPLANT RECIPIENTSTransplantation, 1996
- Use of amphotericin B aerosols for the prevention of pulmonary aspergillosisInfection, 1994
- The indirect effects of cytomegalovirus infection on the outcome of organ transplantationPublished by American Medical Association (AMA) ,1989
- AspergillosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987